PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $59 | -14.5% | 25,943 | -25.7% | 0.01% | 0.0% |
Q4 2023 | $69 | -65.7% | 34,904 | -63.1% | 0.01% | -76.2% |
Q1 2023 | $201 | -99.6% | 94,564 | +54.0% | 0.02% | +425.0% |
Q2 2022 | $48,000 | -48.9% | 61,425 | +342.4% | 0.00% | -55.6% |
Q2 2021 | $94,000 | +46.9% | 13,883 | +5.6% | 0.01% | +200.0% |
Q3 2017 | $64,000 | – | 13,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copernicus Capital Management, LLC | 40,000 | $335,000 | 4.05% |
Opaleye Management Inc. | 1,424,200 | $11,921,000 | 2.23% |
Prosight Management, LP | 282,256 | $2,362,000 | 1.30% |
RTW INVESTMENTS, LP | 6,443,113 | $53,929,000 | 0.81% |
DAFNA Capital Management LLC | 296,383 | $2,481,000 | 0.66% |
Kerrisdale Advisers, LLC | 453,182 | $3,793,000 | 0.41% |
Altium Capital Management LP | 125,000 | $1,046,000 | 0.27% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,079,668 | $17,407,000 | 0.21% |
Alpha Paradigm Partners, LLC | 44,323 | $371,000,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 137,003 | $1,147,000 | 0.12% |